Literature DB >> 34114129

Differentiated Cells Derived from Hematopoietic Stem Cells and Their Applications in Translational Medicine.

Sophia S Fernandes1, Lalita S Limaye1, Vaijayanti P Kale2.   

Abstract

Hematopoietic stem cells (HSCs) and their development are one of the most widely studied model systems in mammals. In adults, HSCs are predominantly found in the bone marrow, from where they maintain homeostasis. Besides bone marrow and mobilized peripheral blood, cord blood is also being used as an alternate allogenic source of transplantable HSCs. HSCs from both autologous and allogenic sources are being applied for the treatment of various conditions like blood cancers, anemia, etc. HSCs can further differentiate to mature blood cells. Differentiation process of HSCs is being extensively studied so as to obtain a large number of pure populations of various differentiated cells in vitro so that they can be taken up for clinical trials. The ability to generate sufficient quantity of clinical-grade specialized blood cells in vitro would take the field of hematology a step ahead in translational medicine.
© 2021. Springer Nature Switzerland AG.

Entities:  

Keywords:  Clinical utility; HSCs in therapeutics; Hematopoietic stem cells (HSCs); Mature blood cells

Mesh:

Year:  2021        PMID: 34114129     DOI: 10.1007/5584_2021_644

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  85 in total

1.  A large number of mature and functional dendritic cells can be efficiently generated from umbilical cord blood-derived mononuclear cells by a simple two-step culture method.

Authors:  Sreekumar Balan; Vaijayanti P Kale; Lalita S Limaye
Journal:  Transfusion       Date:  2010-11       Impact factor: 3.157

2.  Long term cryopreservation in 5% DMSO maintains unchanged CD34(+) cells viability and allows satisfactory hematological engraftment after peripheral blood stem cell transplantation.

Authors:  L Abbruzzese; F Agostini; C Durante; R T Toffola; M Rupolo; F M Rossi; A Lleshi; S Zanolin; M Michieli; M Mazzucato
Journal:  Vox Sang       Date:  2013-02-06       Impact factor: 2.144

3.  Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood.

Authors:  C De Bruyn; A Delforge; P Martiat; D Bron
Journal:  Stem Cells Dev       Date:  2005-08       Impact factor: 3.272

4.  Expansion of primitive human hematopoietic stem cells by culture in a zwitterionic hydrogel.

Authors:  Tao Bai; Jianqiang Li; Andrew Sinclair; Suzan Imren; Fabiola Merriam; Fang Sun; Mary Beth O'Kelly; Cynthia Nourigat; Priyesh Jain; Jeffrey J Delrow; Ryan S Basom; Hsiang-Chieh Hung; Peng Zhang; Bowen Li; Shelly Heimfeld; Shaoyi Jiang; Colleen Delaney
Journal:  Nat Med       Date:  2019-10-07       Impact factor: 53.440

5.  Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation.

Authors:  Stefan O Ciurea; Jolie R Schafer; Roland Bassett; Cecele J Denman; Kai Cao; Dana Willis; Gabriela Rondon; Julianne Chen; Doris Soebbing; Indreshpal Kaur; Alison Gulbis; Sairah Ahmed; Katayoun Rezvani; Elizabeth J Shpall; Dean A Lee; Richard E Champlin
Journal:  Blood       Date:  2017-08-23       Impact factor: 22.113

Review 6.  Hematopoietic stem cell donation.

Authors:  Shu-Huey Chen; Tso-Fu Wang; Kuo-Liang Yang
Journal:  Int J Hematol       Date:  2013-02-19       Impact factor: 2.490

7.  In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells.

Authors:  Eun Jung Baek; Han-Soo Kim; Sinyoung Kim; Honglien Jin; Tae-Yeal Choi; Hyun Ok Kim
Journal:  Transfusion       Date:  2008-07-31       Impact factor: 3.157

8.  Enhanced collection of phenotypic and engrafting human cord blood hematopoietic stem cells at 4°C.

Authors:  Hal E Broxmeyer; Scott Cooper; Maegan L Capitano
Journal:  Stem Cells       Date:  2020-07-04       Impact factor: 6.277

9.  Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics.

Authors:  Laurie Chicha; Anis Feki; Alessandro Boni; Olivier Irion; Outi Hovatta; Marisa Jaconi
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

Review 10.  New paradigms on hematopoietic stem cell differentiation.

Authors:  Hui Cheng; Zhaofeng Zheng; Tao Cheng
Journal:  Protein Cell       Date:  2019-06-14       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.